Mirabegron 50mg 1 Prolonged Release Tablet [Prescription Required]

Indication: For the symptomatic treatment of urgency, increased micturition frequency and/or urgency incontinence as
may occur in adult patients with overactive bladder (OAB) syndrome.
Contraindication: Mirabegron (Betmiga®,) is contraindicated in patients with:
- Hypersensitivity to the active substance or to any of the excipients listed in List of excipients.
- Severe uncontrolled hypertension defined as systolic blood pressure &ge,180 mm Hg and/or diastolic blood pressure &ge,110 mm Hg.

Origin

The Netherlands

Product Usage

The recommended dose is 50 mg once daily with or without food.

Ingredients

List of excipients
Core tablet : Macrogols, Hydroxypropylcellulose, Butylhydroxytoluene, Magnesium stearate
Film coating : Hypromellose, Macrogol, Iron oxide yellow

Warnings

May increase BP. Patients w/ congenital or acquired QT prolongation

Width

1

Height

1

Depth

1